Two Sigma Advisers’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,000
Closed -$319K 1877
2014
Q4
$319K Sell
2,000
-6,000
-75% -$935K ﹤0.01% 1909
2014
Q3
$1.12M Sell
8,000
-5,000
-38% -$653K 0.01% 1072
2014
Q2
$1.54M Buy
13,000
+7,000
+117% +$810K 0.01% 950
2014
Q1
$740K Sell
6,000
-4,000
-40% -$485K 0.01% 1326
2013
Q4
$1.14M Sell
10,000
-6,000
-38% -$683K 0.01% 1061
2013
Q3
$1.79M Sell
16,000
-13,000
-45% -$1.41M 0.02% 687
2013
Q2
$2.86M Buy
+29,000
New +$3.01M 0.04% 392

Other funds holding AMGN

Two Sigma Advisers's AMGN Position: Q1 2026 in Review

Two Sigma Advisers sold out of Amgen (AMGN) in Q1 2026, closing a stake of 735,880 shares — an estimated $241M sold.

Two Sigma Advisers first reported a position in AMGN in Q4 2013 and held it in 48 quarters. The position peaked at $491M in Q2 2019. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Two Sigma Advisers reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 735,880 Amgen shares in Q1 2026, an estimated $241M.
  • Two Sigma Advisers first reported a position in Amgen in Q4 2013 and held it in 48 quarters.
  • Two Sigma Advisers's Amgen position peaked at $491M in Q2 2019.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.